Evidence map›Paper›PMID 38768429›Full record

ArticleBlood advances2024

A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm.

Katarina Zmajkovicova, Sumit Pawar, Svetlana O Sharapova, Christoph B Geier, Ivana Wiest, Chi Nguyen, Halenya Monticelli, Sabine Maier-Munsa, Kelly Chen, John W Sleasman and 17 more

Abstract readCase Reports
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Katarina ZmajkovicovaX4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.ORCID 0000-0002-1394-7039
Sumit PawarFormerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
Svetlana O SharapovaResearch Department, Belarusian Research Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Belarus.ORCID 0000-0003-1390-2348
Christoph B GeierDepartment of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0003-4353-8663
Ivana WiestFormerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
Chi NguyenX4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
Halenya MonticelliX4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.ORCID 0000-0001-6972-8698
Sabine Maier-MunsaFormerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
Kelly ChenX4 Pharmaceuticals, Boston, MA.
John W SleasmanDivision of Allergy, Immunology, Department of Pediatrics, Duke University School of Medicine, Durham, NC.
Svetlana AleshkevichResearch Department, Belarusian Research Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Belarus.
Ekaterina PolyakovaResearch Department, Belarusian Research Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Belarus.ORCID 0000-0002-0706-6622
Inga SakovichResearch Department, Belarusian Research Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Belarus.
Klaus WarnatzDepartment of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-1172-865X
Bodo GrimbacherDepartment of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-6897-6806
Michele ProiettiDepartment of Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany.
Neal SondheimerDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Boglarka UjhaziDivision of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.
Sumai GordonDivision of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.
Maryssa EllisonDivision of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.
Melis YilmazDivision of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.ORCID 0000-0002-8506-7372
Jolan E WalterDivision of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.ORCID 0000-0002-6192-0703
Adriana BadarauFormerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
Arthur G TaverasX4 Pharmaceuticals, Boston, MA.
Jadee L NeffDivision of Hematopathology, Department of Pathology, Duke University, Durham, NC.ORCID 0000-0002-4924-4247
Jacob R BledsoeDepartment of Pathology, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-2387-5462
Teresa K TarrantDivision of Rheumatology and Immunology, Department of Medicine, Duke University, Durham, NC.ORCID 0000-0003-4067-5363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptors, CXCR4FemaleGenetic Association StudiesGenotypeHumansMalePhenotypePrimary Immunodeficiency DiseasesCXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID38768429
PMCPMC11296240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.